Oncoinvent ASA
ONCIN
Ранг среди акций
#27150
Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to... Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to developing innovative radiopharmaceutical treatments for various cancers. Its primary therapeutic agent is Radspherin, an alpha-emitting radiotherapeutic, which is currently undergoing investigation in two Phase 1/2a and one randomized Phase 2 clinical trials. This promising candidate is designed to target and treat malignancies that have metastasized to body cavities, specifically including the peritoneum.
Цена акции
$7.15
Рыночная капитализация
$32.01M
Изменение (1 день)
0.00%
Изменение (1 год)
6,383.25%
Страна
NO
Торговля Oncoinvent ASA (ONCIN)
Категория
Healthcare
История цены акций Oncoinvent ASA (ONCIN)
Наивысшая цена закрытия: $9.10 2026-09-01
Наименьшая цена закрытия: $27.86 2017-12-01
Наименьшая цена закрытия: $27.86 2017-12-01
История цены акций Oncoinvent ASA с 2017 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2026 (TTM) | 268.35% |
| 2025 | 32.73% |
| 2024 | -64.40% |
| 2023 | -90.91% |
| 2022 | 4.70% |
| 2021 | -41.35% |
| 2020 | 114.55% |
| 2019 | -57.70% |
| 2018 | 64.64% |
| 2017 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $536.91 | 25.90% |
US
|
|
| $230.20 | 757.36% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $892.44 | 9.61% |
NL
|
|
| $291.76 | 2.51% |
BE
|
